Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 901 AL 915

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease

Paciotti S, Albi E, Parnetti L, Beccari T.

J Clin Med. 2020 Feb 21;9(2):594. doi: 10.3390/jcm9020594.

PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape

Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B.

Molecules. 2020 Feb 21;25(4):977. doi: 10.3390/molecules25040977.

Physiotherapy for freezing of gait in Parkinson's disease: a systematic review and meta-analysis

Miller KJ, Suárez-Iglesias D, Seijo-Martínez M, Ayán C.

Rev Neurol. 2020 Mar 1;70(5):161-170. doi: 10.33588/rn.7005.2019417.

Transsynaptic tracing and its emerging use to assess graft-reconstructed neural circuits

Adler AF, Björklund A, Parmar M.

Stem Cells. 2020 Jun;38(6):716-726. doi: 10.1002/stem.3166. Epub 2020 Mar 5.

Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease

Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I.

Cochrane Database Syst Rev. 2020 Feb 26;2(2):CD011961. doi: 10.1002/14651858.CD011961.pub2.

Subthalamic Gamma Knife Radiosurgery in Parkinson's Disease: A Cautionary Tale

Drummond PS, Pourfar MH, Hill TC, Mogilner AY, Kondziolka DS.

Stereotact Funct Neurosurg. 2020;98(2):110-117. doi: 10.1159/000505709. Epub 2020 Feb 26.

Considerations for trials of disease modifying treatments in Parkinson disease

Ahlskog JE.

Neurology. 2020 Mar 17;94(11):467-468. doi: 10.1212/WNL.0000000000009127. Epub 2020 Feb 26.

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, Cedarbaum JM, Brundin P, Standaert DG, Lang AE.

Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26.

Gut, oral and nasal microbiota and Parkinson's disease

Shen L.

Microb Cell Fact. 2020 Feb 27;19(1):50. doi: 10.1186/s12934-020-01313-4.

Dropped Head Syndrome: An Update on Etiology and Surgical Management

Brodell JD Jr, Sulovari A, Bernstein DN, Mongiovi PC, Ciafaloni E, Rubery PT, Mesfin A.

JBJS Rev. 2020 Jan;8(1):e0068. doi: 10.2106/JBJS.RVW.19.00068.

Glucocerebrosidase as a therapeutic target for Parkinson's disease

Chen Y, Sam R, Sharma P, Chen L, Do J, Sidransky E.

Expert Opin Ther Targets. 2020 Apr;24(4):287-294. doi: 10.1080/14728222.2020.1733970. Epub 2020 Feb 27.

Coating Materials for Neural Stem/Progenitor Cell Culture and Differentiation

Liu D, Pavathuparambil Abdul Manaph N, Al-Hawwas M, Bobrovskaya L, Xiong LL, Zhou XF.

Stem Cells Dev. 2020 Apr 15;29(8):463-474. doi: 10.1089/scd.2019.0288. Epub 2020 Mar 31.

Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration

Krauss R, Bosanac T, Devraj R, Engber T, Hughes RO.

Trends Pharmacol Sci. 2020 Apr;41(4):281-293. doi: 10.1016/j.tips.2020.01.006. Epub 2020 Feb 24.

Benefits of BCG-induced metabolic switch from oxidative phosphorylation to aerobic glycolysis in autoimmune and nervous system diseases

Faustman DL.

J Intern Med. 2020 Dec;288(6):641-650. doi: 10.1111/joim.13050. Epub 2020 Mar 18.

Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review

Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, Madla CM, Matthys C, Miljuš G, Mooij MG, Parrott N, Ungell AL, de Wildt SN, Orlu M, Klein S, Müllertz A.

Eur J Pharm Sci. 2020 Apr 30;147:105280. doi: 10.1016/j.ejps.2020.105280. Epub 2020 Feb 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias